Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127763421 | 12776342 | 1 | I | 2015 | 20160919 | 20160923 | 20160923 | PER | US-PFIZER INC-2016440607 | PFIZER | 71.00 | YR | F | Y | 48.60000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127763421 | 12776342 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, 1X/DAY | N | 20235 | 100 | MG | CAPSULE, HARD | QD | ||||||
| 127763421 | 12776342 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY | N | 20235 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 127763421 | 12776342 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, 3X/DAY | N | 20235 | 100 | MG | CAPSULE, HARD | TID | |||||
| 127763421 | 12776342 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY | N | 20235 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 127763421 | 12776342 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, 2X/DAY | N | 20235 | 100 | MG | CAPSULE, HARD | BID | ||||||
| 127763421 | 12776342 | 6 | SS | GABAPENTIN. | GABAPENTIN | 1 | 100 MG, UNK (ONCE) | N | 20235 | 100 | MG | CAPSULE, HARD | |||||||
| 127763421 | 12776342 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | 200 MG, UNK (TOOK TWO 100MG ONCE THAT DAY) | N | 20235 | 200 | MG | CAPSULE, HARD | |||||||
| 127763421 | 12776342 | 8 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, UNK | N | 20235 | 600 | MG | CAPSULE, HARD | |||||||
| 127763421 | 12776342 | 9 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 2X/DAY | U | 21446 | 75 | MG | CAPSULE, HARD | BID | ||||||
| 127763421 | 12776342 | 10 | SS | LYRICA | PREGABALIN | 1 | 50 MG, UNK | U | 21446 | 50 | MG | CAPSULE, HARD | |||||||
| 127763421 | 12776342 | 11 | SS | LYRICA | PREGABALIN | 1 | 50 MG, 2X/DAY | U | 21446 | 50 | MG | CAPSULE, HARD | BID | ||||||
| 127763421 | 12776342 | 12 | SS | LYRICA | PREGABALIN | 1 | 50 MG, (ONE CAPSULE) | U | 21446 | 50 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127763421 | 12776342 | 1 | Neuropathy peripheral |
| 127763421 | 12776342 | 2 | Neuralgia |
| 127763421 | 12776342 | 3 | Headache |
| 127763421 | 12776342 | 9 | Neuralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127763421 | 12776342 | Condition aggravated | |
| 127763421 | 12776342 | Drug ineffective for unapproved indication | |
| 127763421 | 12776342 | Drug intolerance | |
| 127763421 | 12776342 | Feeling abnormal | |
| 127763421 | 12776342 | Head discomfort | |
| 127763421 | 12776342 | Headache | |
| 127763421 | 12776342 | Intentional product misuse | |
| 127763421 | 12776342 | Neuralgia | |
| 127763421 | 12776342 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127763421 | 12776342 | 2 | 2015 | 0 | ||
| 127763421 | 12776342 | 3 | 201607 | 20160917 | 0 | |
| 127763421 | 12776342 | 4 | 201608 | 0 | ||
| 127763421 | 12776342 | 5 | 20160914 | 0 | ||
| 127763421 | 12776342 | 6 | 20160915 | 0 | ||
| 127763421 | 12776342 | 7 | 20160916 | 0 | ||
| 127763421 | 12776342 | 9 | 2015 | 0 | ||
| 127763421 | 12776342 | 12 | 20160918 | 0 |